Hua Yang, Ph.D.
Chief Scientific Officer
Dr. Hua Yang is Pharmaron’s Chief Scientific Officer since he started in 2007. In this capacity, he has contributed to leading and building novel drug R&D service platforms, covering preclinical and clinical, particularly for the integration of various platforms, from “end-to-end,” in support of our partners’ needs in the discovery and development of small molecule, large molecule, cell and gene therapy based novel therapeutics.
Prior to joining Pharmaron, Dr. Yang worked in AstraZeneca from 1995 to 2007 on drug-hunting programs. Dr. Yang received his Ph.D. in organic chemistry from Manchester University, UK, post-doc training at University of Montreal, Canada, graduate at Beijing Normal University, China, undergraduate at Jiaxin Teacher’s College, China.